TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/5/24 11:53 | 9/3/24 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kakkis Emil D | CA | DO | P,CEO | S | -1,117 | 55.85 | 0 | -20 | -1 | 2,789 | I | ||||||||||||||
8/7/24 14:48 | 8/6/24 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kakkis Emil D | CA | DO | P,CEO | S | -1,003 | 50.17 | 0 | -20 | -1 | 2,809 | I | ||||||||||||||
2/8/24 15:49 | 2/7/24 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kakkis Emil D | CA | DO | P,CEO | S | -1,350 | 45.00 | 0 | -30 | -1 | 2,804 | D | ||||||||||||||
1/2/24 16:07 | 12/29/23 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kakkis Emil D | CA | DO | P,CEO | S | -1,436 | 47.87 | 0 | -30 | -1 | 2,834 | D | ||||||||||||||
10/23/23 17:14 | 10/19/23 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kakkis Emil D | CA | DO | P,CEO | S.d | -1,604 | 33.52 | 0 | -48 | -2 | 2,864 | D | ||||||||||||||
1/3/23 16:45 | 12/30/22 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kakkis Emil D | CA | DO | P,CEO | S | -892 | 45.57 | 0 | -20 | -1 | 2,824 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |